A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases. . . . → Read More: Biotech Licenses Mayo Clinic Microbiome Research
|
|||||
       |
 One comment - (Comments are closed)  Intellectual property  biomedical, biotechnology, cancer, entrepreneurs, licensing, life sciences, patent, pharmaceuticals A new study finds the U.S. health care system does not have the capacity for large-scale screening and treatment of people with early indicators of Alzheimer’s disease. . . . → Read More: Report: Health System Not Ready for Alzheimer’s Therapies Comments are closed Regulations biomedical, clinical trials, economics, FDA, health care, life sciences, mathematics, physical sciences A clinical trial is underway testing a treatment for solid tumor cancers derived from messenger RNA, genetic material with protein coding instructions for cells. . . . → Read More: Trial Underway Testing Personal RNA Cancer Drug Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, cancer, clinical trials, life sciences, pharmaceuticals A clinical trial testing two leading therapies for opioid abuse found the treatments both safe and effective, even though they work in different ways. . . . → Read More: Two Opioid Addiction Treatments Found Safe, Effective Comments are closed Regulations biomedical, clinical trials, life sciences, NIH, pharmaceuticals, university You have to develop a strong company identity that’ll make them choose you. Here’s some advice on how to turn your IT brand into a mighty brand. . . . → Read More: Helping Your IT Brand Become a Mighty Brand A biotechnology company and two research institutes are collaborating on a study of a proposed cancer treatment that targets the microbiome, communities of bacteria in the human body. . . . → Read More: Alliance Exploring Microbiome on Cancer Immunotherapy 2 comments - (Comments are closed) Joint ventures/collaborations biomedical, cancer, clinical trials, licensing, life sciences, pharmaceuticals, university The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence. . . . → Read More: FDA Clears First Sensor-Pill and App System One comment - (Comments are closed) Joint ventures/collaborations, Regulations biomedical, engineering, FDA, life sciences, medical device, pharmaceuticals, physical sciences, psychiatric, software Janssen Biotech, a division of drug maker Johnson & Johnson, is acquiring technologies that make it possible to create synthetic antibodies that hit multiple targets. . . . → Read More: Zymeworks, Janssen in $1.45B Antibody Licensing Deal 4 comments - (Comments are closed) Intellectual property biomedical, biotechnology, Canada, cancer, licensing, life sciences, mathematics, pharmaceuticals, physical sciences Among the most visible and challenging regulatory issues for companies is security breaches, where companies’ systems are attacked with valuable data stolen. . . . → Read More: Infographic: Largest Hacker Breaches and Regulation Tech A team of ecologists and mathematicians is applying machine learning and statistical models to forecast outbreaks of zoonotic diseases, those spread to humans from animals. . . . → Read More: Math Models to Predict Animal-Borne Disease Outbreaks Comments are closed Finance, New products biomedical, engineering, grant, life sciences, mathematics, medical device, NSF, physical sciences, software, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts